Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiří Litzman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Vnitrni Lekarstvi|March 27, 2019
Primary immunodeficiencies in adultsJiří Litzman
Vnitrni Lekarstvi|March 27, 2019
Treatment of antibody immunodeficiencyJiří Litzman
Vnitrni Lekarstvi|March 17, 2023
Histamine intoleranceRoman Hakl, Jiří Litzman
Vnitrni Lekarstvi|March 27, 2019
Adverse effects of immunoglobulin therapyIva Šutová, Zita Chovancová, Jiří Litzman
International Journal of Immunopathology and Pharmacology|April 11, 2019
Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidaseJiří Litzman, Zita Chovancová, Petr Bejdák, et al.
Expert Review of Clinical Immunology|November 8, 2022
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiencySudhir Gupta, Roger H Kobayashi, Jiří Litzman, et al.
Immunotherapy|January 6, 2022
Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseasesRoger H Kobayashi, Jiří Litzman, Syed Rizvi, et al.
Immunotherapy|December 9, 2024
Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectivesRoger H Kobayashi, Joanna Maltese, Jiří Litzman, et al.
Journal of Clinical Immunology|October 4, 2018
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During PregnancyRoman Hakl, Pavel Kuklínek, Irena Krčmová, et al.
Molecular Biology Reports|April 22, 2023
PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophagesLucie Ballonová, Petra Kulíšková, Peter Slanina, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Vnitrni Lekarstvi|March 27, 2019
Primary immunodeficiencies in adultsJiří Litzman
Vnitrni Lekarstvi|March 27, 2019
Treatment of antibody immunodeficiencyJiří Litzman
Vnitrni Lekarstvi|March 17, 2023
Histamine intoleranceRoman Hakl, Jiří Litzman
Vnitrni Lekarstvi|March 27, 2019
Adverse effects of immunoglobulin therapyIva Šutová, Zita Chovancová, Jiří Litzman
International Journal of Immunopathology and Pharmacology|April 11, 2019
Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidaseJiří Litzman, Zita Chovancová, Petr Bejdák, et al.
Expert Review of Clinical Immunology|November 8, 2022
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiencySudhir Gupta, Roger H Kobayashi, Jiří Litzman, et al.
Immunotherapy|January 6, 2022
Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseasesRoger H Kobayashi, Jiří Litzman, Syed Rizvi, et al.
Immunotherapy|December 9, 2024
Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectivesRoger H Kobayashi, Joanna Maltese, Jiří Litzman, et al.
Journal of Clinical Immunology|October 4, 2018
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During PregnancyRoman Hakl, Pavel Kuklínek, Irena Krčmová, et al.
Molecular Biology Reports|April 22, 2023
PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophagesLucie Ballonová, Petra Kulíšková, Peter Slanina, et al.
Pageof 2